Study: Majority of parents give children wrong dosage of medicin - Tucson News Now

Study: Majority of parents give children wrong dosage of medicine

(Source: Tucson News Now) (Source: Tucson News Now)
PIMA COUNTY, AZ ( Tucson News Now) -

Parents, your small mistake could put your child in the hospital this cold and flu season.

According to the Arizona Poison and Drug Information Center, last year roughly 1,500 children under five years ago were treated for medicine overdose in Pima County alone.

The number was a little lower for children ages 6-19 years old.

Last year, 1,200 kids in Southern Arizona were treated for medicine exposure.

According to the study published in Pediatrics, more than 65 percent of parents are unknowingly overdosing their children, and more than 80 percent of parents are making a dosing error when giving their children medication.

Local experts at the University of Arizona say the mistakes could be dangerous and potentially deadly.

Hanna Phan, associate professor in  the UA College of Pharmacy, says parents need to ask questions.

“Communication between you, your pharmacist, your physician, your nurse about what medications you’re giving, the concentration of that medication, because liquids do come in variable concentrations, as well as the amount in terms of volume,” Phan said.

She also recommends parents use oral syringes instead of dosing cups.

It is easier to see just how much medication you are giving your child and that reduces the risk of a deadly mistake.

“There are still devices out there that you will see over the counter, that are still going to have those little measuring cups in them. If you don’t feel comfortable using them given this new study, feel free to go to the pharmacist counter and ask them what is the best way of administering this medication to your child,” Phan said.

More information can be found below:

Copyright 2016 Tucson News Now. All rights reserved. 

  • HealthHealthMore>>

  • Bayer to stop sales of birth control device tied to injuries

    Bayer to stop sales of birth control device tied to injuries

    Friday, July 20 2018 12:14 PM EDT2018-07-20 16:14:15 GMT
    Sunday, July 22 2018 5:12 PM EDT2018-07-22 21:12:04 GMT
    (Bayer Healthcare Pharmaceuticals via AP). FILE - This image provided by Bayer Healthcare Pharmaceuticals shows the birth control implant Essure. On Friday, July 20, 2018, the maker of the permanent contraceptive implant subject to thousands of injury ...(Bayer Healthcare Pharmaceuticals via AP). FILE - This image provided by Bayer Healthcare Pharmaceuticals shows the birth control implant Essure. On Friday, July 20, 2018, the maker of the permanent contraceptive implant subject to thousands of injury ...
    The maker of a permanent birth control implant said Friday it will stop selling the device in the U.S. at the end of the year.
    The maker of a permanent birth control implant said Friday it will stop selling the device in the U.S. at the end of the year.
  • Flint water crisis prompts call for more federal oversight

    Flint water crisis prompts call for more federal oversight

    Thursday, July 19 2018 2:46 PM EDT2018-07-19 18:46:02 GMT
    Sunday, July 22 2018 5:11 PM EDT2018-07-22 21:11:57 GMT
    A federal watchdog is calling on the Environmental Protection Agency to strengthen its oversight of state drinking water systems in the wake of the lead crisis in Flint, Michigan.
    A federal watchdog is calling on the Environmental Protection Agency to strengthen its oversight of state drinking water systems in the wake of the lead crisis in Flint, Michigan.
  • Simpler, one-dose treatment to prevent malaria relapse OK'd

    Simpler, one-dose treatment to prevent malaria relapse OK'd

    Friday, July 20 2018 6:04 PM EDT2018-07-20 22:04:04 GMT
    Sunday, July 22 2018 5:11 PM EDT2018-07-22 21:11:54 GMT
    (AP Photo/Kirsty Wigglesworth, File). FILE - This April 28, 2010, file photo shows the GlaxoSmithKline offices in London. On Friday, July 20, 2018, the U.S. Food and Drug Administration approved GlaxoSmithKline’s Krintafel, a simpler, one-dose treatmen...(AP Photo/Kirsty Wigglesworth, File). FILE - This April 28, 2010, file photo shows the GlaxoSmithKline offices in London. On Friday, July 20, 2018, the U.S. Food and Drug Administration approved GlaxoSmithKline’s Krintafel, a simpler, one-dose treatmen...
    U.S. regulators approve a simpler, one-dose treatment to prevent relapses of malaria.
    U.S. regulators approve a simpler, one-dose treatment to prevent relapses of malaria.
Powered by Frankly